<DOC>
	<DOCNO>NCT02657512</DOCNO>
	<brief_summary>Rivaroxaban direct oral anticoagulant target specifically activated factor X . Bleeding event related rivaroxaban consequence physiopathologic , pharmacokinetic issue poison . Few result available use activate charcoal rivaroxaban poisoning . Moreover , recent study , healthy subject , show activate charcoal reduce significantly exposition apixaban ( direct oral anticoagulant class ) . The objective study evaluate effect activate charcoal rivaroxaban pharmacokinetics . It correspond randomised open trial incomplete cross design ( 3 occasion ) . It enrol 12 healthy subject . Four treatment modality study : rivaroxaban alone rivaroxaban activated charcoal administrate 2 , 4 8 hour rivaroxaban administration .</brief_summary>
	<brief_title>Effect Activated Charcoal Rivaroxaban Pharmacokinetics Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>affiliated beneficiary social security category sign inform consent form sign genetic consent form BMI 18.5 25 normal clinical exam normal biological exam contraindication rivaroxaban contraindication activate charcoal previous history psychiatric disease , antidepressant treatment , convulsion , hemorrhagic disease smoker Organic lesion likely bleed severe liver disease severe kidney failure previous surgery within one month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Rivaroxaban , pharmacokinetics , activate charcoal , poison</keyword>
</DOC>